Featured Research

from universities, journals, and other organizations

For osteoporosis patients, exercise pill one step closer to reality

Date:
April 8, 2010
Source:
Federation of American Societies for Experimental Biology
Summary:
For osteoporosis patients unable to exercise, help may be on the way. That's because scientists have discovered precisely how mechanical stress, such as exercise, promotes new bone growth. This opens the door to entirely new therapies that can trick bones into thinking they are getting a workout.

For osteoporosis patients unable to exercise, help may be on the way. That's because scientists have discovered precisely how mechanical stress, such as exercise, promotes new bone growth. This opens the door to entirely new therapies that can trick bones into thinking they are getting a workout. The research report describing this advance is published online in The FASEB Journal.

This research provides insight into the identification of the signaling mechanisms used by primary cilia to regulate the capacity of bone cells to sense fluid flow. This crucial information could lead to the development of new drugs that cause the same benefits to the skeleton as exercise, which would be beneficial to patients with osteoporosis.

"We believe that this study takes the field an important step forward in answering a two hundred-year-old question, 'How does bone sense mechanical loads?'" said Christopher R. Jacobs, Ph.D., co-author of the study from the Department of Mechanical Engineering at Stanford University in Stanford, CA. "Ultimately, we hope that the mechanisms identified in this study can be exploited to develop novel treatments for bone loss and perhaps a large number of other diseases involving the remarkably versatile primary cilia."

The research by Jacobs and colleagues builds on existing knowledge about the role of primary cilia (hair-like organelles that line the surfaces of some cells) on fluid flow in bone cells. When bone carries weight during physical exercise, bone cells are subjected to fluid flow, which is detected by primary cilia in bone cells. To make their discovery, the scientists studied an enzyme found in bone cells called adenylyl cyclase 6 (AC6), which is compartmentalized within the primary cilia. This enzyme inactivates very quickly in response to fluid flow, which initiates a signaling cascade that ultimately leads to increased expression of bone-forming genes. Researchers exposed bone cells to fluid flow and measured the intracellular levels of cyclic AMP, a signaling molecule synthesized by AC6, and found the levels quickly decreased after a two-minute bout of fluid flow. When scientists used RNA interference to inhibit the formation of primary cilia, as well as the production of AC6, the levels did not decrease in response to fluid flow. Results suggest that the short bout of fluid flow was sufficient to increase expression of a gene important for bone formation called cyclo-oxygenase 2. This study is one of the first to suggest that primary cilia play an important role in diseases such as osteoporosis.

"It's easy for doctors to tell osteoporosis patients that they need to get a good workout a few days each week, but the reality is that many patients are too frail to do so," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "This ground-breaking study details the exact biochemical signals used by bone cells to turn the daily work-out into new bone. This research pinpoints new targets for drugs that will allow physicians to break this cycle of frailty, bone loss, and incapacity, so that patients can live longer, healthier, and more active lives."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kwon et al. Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells. The FASEB Journal, 2010; DOI: 10.1096/fj.09-148007

Cite This Page:

Federation of American Societies for Experimental Biology. "For osteoporosis patients, exercise pill one step closer to reality." ScienceDaily. ScienceDaily, 8 April 2010. <www.sciencedaily.com/releases/2010/04/100407094454.htm>.
Federation of American Societies for Experimental Biology. (2010, April 8). For osteoporosis patients, exercise pill one step closer to reality. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/04/100407094454.htm
Federation of American Societies for Experimental Biology. "For osteoporosis patients, exercise pill one step closer to reality." ScienceDaily. www.sciencedaily.com/releases/2010/04/100407094454.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins